Ally Financial Inc. Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Ally Financial Inc. acquired a new stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 3,000 shares of the company’s stock, valued at approximately $900,000.

Several other large investors have also recently modified their holdings of HCA. Jump Financial LLC increased its position in HCA Healthcare by 1,470.4% during the fourth quarter. Jump Financial LLC now owns 12,218 shares of the company’s stock valued at $3,667,000 after acquiring an additional 11,440 shares during the last quarter. Bridgewater Associates LP raised its position in HCA Healthcare by 88.2% in the 4th quarter. Bridgewater Associates LP now owns 470,553 shares of the company’s stock worth $141,236,000 after purchasing an additional 220,512 shares during the period. Ontario Teachers Pension Plan Board boosted its position in shares of HCA Healthcare by 47.0% during the fourth quarter. Ontario Teachers Pension Plan Board now owns 7,388 shares of the company’s stock valued at $2,218,000 after buying an additional 2,362 shares during the period. Aware Super Pty Ltd as trustee of Aware Super purchased a new stake in shares of HCA Healthcare in the fourth quarter worth approximately $29,846,000. Finally, Canada Post Corp Registered Pension Plan purchased a new position in HCA Healthcare during the 4th quarter valued at $944,000. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on HCA shares. Cantor Fitzgerald reissued an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. Royal Bank of Canada reduced their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research report on Monday, January 27th. KeyCorp dropped their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Truist Financial lowered their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Bank of America lowered their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $381.67.

Read Our Latest Stock Report on HCA

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Down 1.2 %

HCA Healthcare stock opened at $331.41 on Thursday. The business has a fifty day moving average price of $328.02 and a 200-day moving average price of $335.60. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The stock has a market capitalization of $81.59 billion, a price-to-earnings ratio of 15.08, a PEG ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the company posted $5.90 earnings per share. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.87%. The ex-dividend date of this dividend was Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is presently 13.11%.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.